Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
1(13%)
Results Posted
50%(1 trials)
Terminated
1(13%)

Phase Distribution

Ph not_applicable
2
25%
Ph phase_4
3
38%
Ph phase_3
3
38%

Phase Distribution

0

Early Stage

0

Mid Stage

6

Late Stage

Phase Distribution8 total trials
Phase 3Large-scale testing
3(37.5%)
Phase 4Post-market surveillance
3(37.5%)
N/ANon-phased studies
2(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

1

trials recruiting

Total Trials

8

all time

Status Distribution
Active(1)
Completed(2)
Terminated(1)
Other(4)

Detailed Status

unknown4
Completed2
Recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
1
Success Rate
66.7%
Most Advanced
Phase 4

Trials by Phase

Phase 33 (37.5%)
Phase 43 (37.5%)
N/A2 (25.0%)

Trials by Status

recruiting113%
unknown450%
terminated113%
completed225%

Recent Activity

1 active trials
Showing 5 of 8
recruitingphase_3

A Study to Compare the Efficacy and Safety of Follitropin Alfa/Lutropin Alfa Versus hMG in Japanese Participants With LH and FSH Deficiency Undergoing ART (HINATA)

NCT07340827
unknownphase_3

Dydrogesterone, Cetrorelix Acetate and Triptorelin in Intra Cytoplasmic Sperm Injection Outcomes

NCT05972902
unknownnot_applicable

Testosterone and Neurovascular Control in Humans

NCT04819204
terminatedphase_4

Patients' Preference for Subcutaneous or Vaginal Progesterone as Luteal Support in IVF/ICSI Cycles

NCT03181685
unknownphase_4

Frozen Embryo Transfer With GnRH-antagonist Trial

NCT03763786
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT07340827Phase 3

A Study to Compare the Efficacy and Safety of Follitropin Alfa/Lutropin Alfa Versus hMG in Japanese Participants With LH and FSH Deficiency Undergoing ART (HINATA)

Recruiting
NCT05972902Phase 3

Dydrogesterone, Cetrorelix Acetate and Triptorelin in Intra Cytoplasmic Sperm Injection Outcomes

Unknown
NCT04819204Not Applicable

Testosterone and Neurovascular Control in Humans

Unknown
NCT03181685Phase 4

Patients' Preference for Subcutaneous or Vaginal Progesterone as Luteal Support in IVF/ICSI Cycles

Terminated
NCT03763786Phase 4

Frozen Embryo Transfer With GnRH-antagonist Trial

Unknown
NCT03477929Phase 4

Cetrorelix and Ganirelix Flexible Protocol for (IVF)

Unknown
NCT01185704Phase 3

Analysis of Two Therapeutic With Cetrotide® in Polycystic Ovarian (PCO) Women in Assisted Reproductive Technology (ART)

Completed
NCT00571870Not Applicable

Gonadotropin-releasing Hormone Antagonist on Triggering Day: A Randomized Controlled Study

Completed

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8